Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2008
10/16/2008CA2682347A1 A medicament for treating schizophrenia comprising cilostazol
10/16/2008CA2681864A1 Crystalline forms i and ii of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine
10/16/2008CA2681163A1 Heterocycles as orexin antagonists
10/15/2008EP1980271A1 Medicine for transnasal administration
10/15/2008EP1980261A1 Use of helium with oxygen to provide neuroprotection
10/15/2008EP1980260A1 Use of hyperbaric conditions to provide neuroprotection
10/15/2008EP1980254A1 Means and methods for counteracting protein aggregation
10/15/2008EP1980252A2 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
10/15/2008EP1980249A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
10/15/2008EP1979350A1 Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of alzheimer's disease via gaba receptors
10/15/2008EP1979343A2 Bicyclic heteroaryl compounds as pde10 inhibitors
10/15/2008EP1979324A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer's disease, neurodegeneration and dementia
10/15/2008EP1979322A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
10/15/2008EP1979321A1 Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
10/15/2008EP1979320A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/15/2008EP1979317A1 Benzoisoindole derivatives for the treatment of pain
10/15/2008EP1979316A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
10/15/2008EP1979308A1 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
10/15/2008EP1978995A1 Method for the treatment and/or prophylaxis of multiple sclerosis, and use of erythropoietin for the manufacture of a medicament for the intermittent treatment and/or intermittent prophylaxis of multiple sclerosis
10/15/2008EP1978967A1 Quinazolinone derivatives as vanilloid antagonists
10/15/2008EP1978962A2 Compositions and methods of treatment using modulators of motonueron diseases
10/15/2008EP1896416B1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
10/15/2008EP1685105B1 Allosteric modulators of metabotropic glutamate receptors
10/15/2008EP1680127B1 Benzazepine derivatives as mao-b inhibitors
10/15/2008EP1660085B1 Pyridylpyrrole derivatives active as kinase inhibitors
10/15/2008EP1628656B1 Gabapentin tannate in liquid and/or semi-solid dosage forms
10/15/2008EP1603901B1 Tetrahydropyran compounds as tachykinin antagonists
10/15/2008EP1567667B1 Treatment of huntington's disease with epa
10/15/2008EP1465617B1 Process for affecting neurologic progression
10/15/2008EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/15/2008EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
10/15/2008EP1453798B1 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
10/15/2008EP1444202B1 Novel metalloproteinase inhibitors
10/15/2008EP1432379B1 Methods for inhibiting cognitive deterioration in adults with down's syndrome
10/15/2008EP1383503B1 Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops
10/15/2008EP1383497B1 Carbonic anhydrase activators for enhancing learning and memory
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1319008B1 Water soluble rapamycin esters
10/15/2008EP1303600B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
10/15/2008EP1282703B1 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
10/15/2008EP1272517B1 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/15/2008EP1272515B1 Immunoregulator
10/15/2008EP1173432B9 Piperidine-indole compounds having 5-ht6 affinity
10/15/2008EP1126826B1 Multiparticulate modified release composition of methylphenidate
10/15/2008EP1019057B1 A method of preventing or treating estrogen-dependent diseases and disorders
10/15/2008EP0363415B1 Compounds for the treatment of alzheimer's disease
10/15/2008CN101287738A Imidazo benzodiazepine derivatives
10/15/2008CN101287732A Modulators of cystic fibrosis transmembrane conductance regulator
10/15/2008CN101287730A Glucuronate salt of a piperazine compound
10/15/2008CN101287723A Amide alkyl pyridiyl quinolines as nk3 receptor modulators
10/15/2008CN101287722A Substituted piperazines as metabotropic glutamate receptor antagonists
10/15/2008CN101287719A Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
10/15/2008CN101287718A Substituted heteroaryl- and phenylsulfamoyl compounds
10/15/2008CN101287712A Heterocyclic compounds
10/15/2008CN101287486A Method of improving learning and memory in mammals
10/15/2008CN101287459A Carbamate compounds for use in treating neurodegenerative disorders
10/15/2008CN101287458A Composition for use in prevention of hypoglycemic condition
10/15/2008CN101287445A Oral, rapidly disintegrating film, which cannot be spat out, for a neuroleptic
10/15/2008CN101287444A Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent
10/15/2008CN101285064A Novel conus P-superfamily toxin sequence, preparation method and uses thereof
10/15/2008CN101285063A Novel conus P-superfamily toxin, sequence and uses thereof
10/15/2008CN101284868A Peptides hydration salt compounds and stereoisomers thereof
10/15/2008CN101284859A Panaxadiol saponin microbial conversion hydrolysate and method for preparing same
10/15/2008CN101284858A Panaxadiol saponin microbial conversion products and method for preparing same
10/15/2008CN101284828A Cycloheptapyridine compounds, preparation method thereof, use and pharmaceutical compositions containing the compounds
10/15/2008CN101284812A Tacrine-ferulaic acid hetero-blend, preparation method and pharmaceutical compositions thereof
10/15/2008CN101284128A Medicine for relieving or neutralizing the effect of alcohol and resisting intoxication and preparation method thereof
10/15/2008CN101284105A Thrombolysis lipid-lowering pellet for curing cardio-cerebrovascular disease
10/15/2008CN101284098A Medicine for curing nervous headache
10/15/2008CN101284092A Medicinal composition for preventing birth defect and improving the memory
10/15/2008CN101284083A Externally used medicament for curing the facial nerve paralysis and preparation method thereof
10/15/2008CN101284081A Medicine for relieving or neutralizing the effect of alcohol and preparation method thereof
10/15/2008CN101284064A Preparation method of Gelan lipid-reducing antialcoholic drug
10/15/2008CN101284058A Sobering-up agent and its preparation process
10/15/2008CN101284054A Externally-applied drug for treating insomnia
10/15/2008CN101284043A Plaster for treating facial paralysis and preparation method thereof
10/15/2008CN101284037A Gadol extract and preparation method thereof
10/15/2008CN101284019A Medicine for treating insomnia and preparation method
10/15/2008CN101283995A Different pharmaceutical uses alpha2delta ligands
10/15/2008CN101283994A Application of plumbagin in preparing the medicine for preventing the blood vessel from regenerating
10/15/2008CN101283965A Preparation containing bendopa methyl ester and preparation method thereof
10/15/2008CN101283828A Beverage for sobering up, reducing fever and protecting liver
10/15/2008CN101283807A PUFA supplements
10/15/2008CN101283793A Health-care products for cleaning the fume poison in vivo and its preparation method
10/15/2008CN101283787A Novel food for stopping smoking and its preparation method
10/15/2008CN100425702C Lentiviral triplex DNA, and vectors and recombinant cells contg. same
10/15/2008CN100425692C Method for preparing rabbitpox culturing tissue containing high-quality physiological activity
10/15/2008CN100425608C Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
10/15/2008CN100425600C Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as CDC25 phosphatase inhibitors
10/15/2008CN100425592C Indole derivatives
10/15/2008CN100425274C Insomnia treating Chinese medicine
10/15/2008CN100425239C Therapeutic applications of 2-substituted 4-heteroarylpyrimidines
10/15/2008CN100425233C Nimodipine gel for nasal cavity
10/15/2008CN100425160C Danshi food and preparing method
10/15/2008CN100425159C Health food and its preparing method
10/15/2008CN100425146C Higher unsaturated fatty acid composition
10/14/2008US7435872 Role of p62 in aging-related disease
10/14/2008US7435838 Mixture of both S- and R-enantiomers of 3-hydroxymethyl-4-[1-(p-fluorophenyl)-1-hydroxyl-4-(dimethylamino)]butylbenzonitrile; dissolving the intermediate free base oil in a single- or multi-component solvent, and crystallizing one or more times
10/14/2008US7435834 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/14/2008US7435749 Beverage treated with nicotine
1 ... 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 ... 1833